Professor, Medicine, Michigan State University, College of Human Medicine
Infectious Disease
Dr. Daniel H. Havlichek, MD
|
|
Give Review
Daniel H. Havlichek, MD works in the field of Infectious Disease. He attended University of Michigan Medical School. Daniel Havlichek is also a published MD. He has 22 paper published. The most recent paper is: Newer oral antimicrobials for resistant respiratory tract pathogens. Which show the most promise? He accepts Medicare.
Publications
- Infectious diseases subspecialty: declining demand challenges and opportunities.
- Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection.
- Pharmacokinetics and monte carlo simulations of doripenem in patients with febrile neutropenia.
- Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
- Immunizations for the college student: a campus perspective of an outbreak and national and international considerations.
- Age-related hepatitis B seroconversion rates in health care workers.
- A physiological role for luminal gastrin?
- A 20-year-old man with fever, headache, and neck stiffness. Neuroborreliosis with tick-borne relapsing fever.
- Cardiovascular manifestations in human immunodeficiency virus-infected patients.
- Subdeltoid bursitis: an unusual presentation of Streptococcus pneumoniae bacterial endocarditis.
- Comparison of chlamydial culture with Chlamydiazyme assay during erythromycin PCE treatment of Chlamydia genital infections.
- High prevalence of historical risk factors for blood-borne infections among inpatients at three community hospitals.
- Legionella lansingensis sp. nov. isolated from a patient with pneumonia and underlying chronic lymphocytic leukemia.
- False-positive HIV diagnosis by HIV-1 plasma viral load testing.
- Newer oral antimicrobials for resistant respiratory tract pathogens. Which show the most promise?
- Sparfloxacin: potential clinical and economic impact in the treatment of respiratory infections.
- A preliminary study of clarithromycin versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis.
- Primary prevention and international travel: infections, immunizations, and antimicrobial prophylaxis.
- The new macrolide antibiotics. Azithromycin and clarithromycin.
- Media notification of the Michigan influenza outbreak, 1999-2000.
- Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patie...
Schools
University Of Michigan Medical School
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Henry Ford Hospital - Wayne State University -
University of Michigan Medical School
Drug Facts
| NPI NUMBER | 1336176494 | |
| NPPES Provider LastName | HAVLICHEK | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 488247037 | |
| NPPES Provider State | MI | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 228.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336176494 |
| Last Name Of The Provider | HAVLICHEK |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Apoorv Y. Kalra, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig L. Hutchinson, MD |
|
|
Dr. Subhashis Mitra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maryann Tran, MD |